Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years
Matthew J. Colombo, Kim Papp, Victoria Berger, Shinichi Imafuku et al.
Citations
32 citations
Journal
JAMA Dermatology
Topics
Psoriasis: Treatment and Pathogenesis
Field-Weighted Citation Impact (FWCI)
7.70
article
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years
Matthew J. Colombo, Kim Papp, Victoria Berger, Shinichi Imafuku, Lynda Spelman, April Wang Armstrong, Thierry Passeron, Mark Lebwohl, Kim Hoyt, Mamitaro Ohtsuki, Renata M. Kisa, Howard Sofen, Andrew Blauvelt, Richard Bruce Warren, Diamant Thaçi, Julie Scotto, Bruce E Strober, Subhashis Banerjee, John Vaile, Eleni Vritzali
article en
32 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA DermatologyVol. 161(1)
Institutions
Jichi Medical University (JP), University of California, Los Angeles (US), University of Toronto (CA), Université Côte d'Azur (FR), Manchester Academic Health Science Centre (GB), Northern Health and Social Care Trust (GB), Yale University (US), Bristol-Myers Squibb (United States) (US), Fukuoka University Hospital (JP), Manchester University NHS Foundation Trust (GB), Probity Medical Research (CA), Oregon Medical Research Center (US), Central Dermatology (US), Veracity Clinical Research (AU), NIHR Manchester Biomedical Research Centre (GB), Bristol-Myers Squibb (Switzerland) (CH), University of Lübeck (DE), Icahn School of Medicine at Mount Sinai (US)